Sources and work object
Policies, SOPs, templates, project files and selected external requirements form the bounded context.
WHO IT IS FOR · DOES IT FIT US?
Whether pharma, medical devices, biotech, contract manufacturers (CDMO/CMO) or contract research (CRO): traqx prepares research, drafts, document updates and traceability from controlled sources — source, status and open points stay visible. Your systems and your release process remain authoritative.
No obligation · personal · straight in the calendar
YOUR WORKING REALITY
Each page starts from different work objects and boundaries. The product logic stays the same: an industry page promises you nothing traqx cannot already do.
01 · Pharma
For quality teams working across distributed controlled sources with clear QA responsibility.
02 · Medical devices
For QA/RA teams, without implying replacement of an eQMS, RIM or design-control system.
03 · Biotech
For the actual regulated scope, not automatically for every research activity.
04 · CDMO / CMO
For contract manufacturers: it stays visible which requirement applies and who is accountable for what.
05 · Contract research organization (CRO)
For quality work in the applicable scope. traqx does not replace your trial systems (CTMS, eTMF, EDC).
SHARED MECHANISM
traqx prepares work inside the defined source room. Professional assessment, correction and decision remain with the responsible expert.
Policies, SOPs, templates, project files and relevant external requirements form the controlled context.
traqx researches inside the source room and prepares drafts, document updates and traceability suggestions.
Source, section, status and open points remain visible and reviewable on the work object.
Experts review, correct, accept or reject; the existing release process remains authoritative.
Policies, SOPs, templates, project files and selected external requirements form the bounded context.
Research and cite inside a controlled source room, update documents and prepare traceability candidates.
Assess sources, suggestions and open points; the existing release process remains authoritative.
EVIDENCE, NOT A MARKETING CLAIM
The product dossiers show real traqx views with synthetic demo data. Industry fit follows from your process and your scope — not from a reference claim.
FAQ
traqx fits pharmaceutical, medical device, biotech, CDMO/CMO and CRO quality teams when traqx is used to prepare research, drafts, document updates and traceability from controlled sources before their subject-matter experts review the result. traqx does not replace an eQMS, DMS, QMS, MES, CTMS or another system of record, and it makes no autonomous quality or release decision.
traqx researches and cites inside controlled source rooms, prepares drafts and traceability candidates, and can return existing documents as Word files with tracked changes, source or rationale comments and an updated version history, and show the document state in traqx. The expert reviews and decides. Document-based use cases are included and share the same source, template and review logic.
The expert checks sources, corrects or rejects the groundwork, assesses open points and decides through the existing quality and release process. traqx does not set a draft to released autonomously.
No. The actual process and regulatory context decide. Especially in biotech, medical devices and CROs, traqx does not infer a blanket GxP classification from the industry label.
No. Depending on the architecture, traqx can work as a standalone platform or connect to an existing system landscape. Forced replacement of an eQMS, DMS or another system of record is not part of the proposition.
CLARIFIED IN THE MEETING
We show the controlled source room, concrete agent task, reviewable result and system boundary on your quality process.
No obligation · personal · straight in the calendar